Invention Grant
- Patent Title: Crystalline forms of tryosine kinase inhibitors and their salts
- Patent Title (中): 谷氨酸激酶抑制剂及其盐的结晶形式
-
Application No.: US14208244Application Date: 2014-03-13
-
Publication No.: US08999992B2Publication Date: 2015-04-07
- Inventor: Jay Jie-Qiang Wu , Ling Wang
- Applicant: VM Pharma LLC
- Applicant Address: US CA Fremont
- Assignee: VM Pharma LLC
- Current Assignee: VM Pharma LLC
- Current Assignee Address: US CA Fremont
- Agency: Cooley LLP
- Main IPC: A61K31/495
- IPC: A61K31/495 ; C07D261/20
Abstract:
The invention relates to various polymorphic forms and amorphous form of sodium 4-((3-(4-cyclohexylpiperazin-1-yl)-6-oxo-6H-anthra[1,9-cd]isoxazol-5-yl)amino)benzate, including the polymorphic form A, mixtures of the polymorphs, process for the preparation thereof and the use thereof in a pharmaceutical composition containing thereof.
Public/Granted literature
- US20140275113A1 CRYSTALLINE FORMS OF TRYOSINE KINASE INHIBITORS AND THEIR SALTS Public/Granted day:2014-09-18
Information query
